Singapore markets closed

Biolidics Limited (8YY.SI)

SES - SES Delayed price. Currency in SGD
Add to watchlist
0.0120+0.0010 (+9.09%)
At close: 04:21PM SGT
Currency in SGD

Valuation measures4

Market cap (intra-day) 9.34M
Enterprise value 11.18M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.41
Price/book (mrq)N/A
Enterprise value/revenue 8.50
Enterprise value/EBITDA -5.24

Trading information

Stock price history

Beta (5Y monthly) 0.69
52-week change 3-29.41%
S&P500 52-week change 323.10%
52-week high 30.0190
52-week low 30.0100
50-day moving average 30.0118
200-day moving average 30.0135

Share statistics

Avg vol (3-month) 3951.25k
Avg vol (10-day) 386.89k
Shares outstanding 5778.27M
Implied shares outstanding 6778.27M
Float 8447.38M
% held by insiders 145.95%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -182.81%
Operating margin (ttm)-1,272.73%

Management effectiveness

Return on assets (ttm)-45.57%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)1.36M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-92.30%
Gross profit (ttm)N/A
EBITDA -2.41M
Net income avi to common (ttm)-2.49M
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)183k
Total cash per share (mrq)0
Total debt (mrq)2.02M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.22
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)-1.97M
Levered free cash flow (ttm)-4.84M